title: Interstitial magnetic resonance lymphography using a polymeric t1 contrast agent: initial experience with Gadomer-17.
abstract: OBJECTIVE
  The detection of lymph node metastases is an important step in tumor staging and is significant for therapy planning. Lymph node-specific contrast agents can raise the sensitivity and specificity of modern diagnostic methods. This study investigated the suitability of the dendritic contrast agent Gadomer-17 in magnetic resonance (MR) lymph node imaging and compared three different dosages in such an application.
  
  
  METHODS
  Doses of 1.0, 2.5, and 10.0 micromol Gd/kg body weight were interstitially injected into the hind legs of dogs; the signal intensities of two successive lymph node groups (inguinal and iliacal) were then recorded up to 120 minutes after injection.
  
  
  RESULTS
  Gadomer-17 induced a strong increase in signal intensity of the examined lymph node groups. At 15 minutes postinjection, the enhancement increased by 120% to 680%, depending on the dose. The maximum enhancement was 450% to 960% at 60 to 90 minutes postinjection. Doses of 2.5 and 10.0 micromol Gd/kg showed comparable results; even the lowest dose (1.0 micromol Gd/kg) enhanced the contrast of the inguinal lymph nodes in 4 of 5 animals and the iliacal lymph nodes in three of five animals. Therefore, the minimum effective dose of Gadomer-17 in this study was approximately 2.5 micromol Gd/kg.
  
  
  CONCLUSIONS
  This study revealed the excellent suitability of the dendritic contrast agent Gadomer-17 for MR imaging of the lymphatic system (lymph nodes and lymph vessels).
authors.affiliation: Diagnostic Imaging Division, Contrast Media Research, Research Laboratories, Schering AG, Müllerstrasse 178, 13342 Berlin, Germany. bernd.misselwitz@schering.de
authors.forename: Bernd
authors.initials: B
authors.lastname: Misselwitz
authors.forename: Heribert
authors.initials: H
authors.lastname: Schmitt-Willich
authors.forename: Marten
authors.initials: M
authors.lastname: Michaelis
authors.forename: Johann J
authors.initials: JJ
authors.lastname: Oellinger
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage*; D004285:Dogs; D005682:Gadolinium; D008220:Lymphography / Q000379:methods*; D008279:Magnetic Resonance Imaging
chemical_list: D003287:Contrast Media; C402765:gadomer 17; D005682:Gadolinium